The threat of multidrug-resistant microorganisms: active surveillance of key antimicrobial resistant pathogens in 2025 - a report from the INVIFAR network
European Journal of Clinical Microbiology & Infectious Diseases · 2026
DOI: 10.1007/s10096-025-05330-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2026. Verfasst von Adrián Martínez-Meléndez und 59 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, 66455, Mexico. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Resistance, Multiple, Bacterial, Bacteria, Bacterial Infections. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Systematic collection and analysis of antimicrobial resistance data from key bacterial pathogens is essential to contribute to control antimicrobial resistance (AMR). The aim of this work was to survey the drug resistance on clinically relevant organisms stratified according to age, gender, clinical specimens and facilities.
Methods
Microbiological data were collected from 55 centers across 24 states in Mexico between January 1 and March 31, 2025. Bacterial identification and antimicrobial susceptibility testing were performed at each participating center using locally available methods. Data was processed using WHONET 2025. Isolates obtained from lower respiratory specimens, urine, blood, biopsies and abscesses were analyzed. Carbapenem non-susceptible isolates were further analyzed by PCR for common carbapenemase-encoding genes. Resistance frequencies were compared using the chi-square test.
Results
A total of 11,290 clinical isolates were analyzed, mostly from urine ( n = 7,149; 63.3%), followed by blood ( n = 1,370; 12.1%). The most prevalent was Escherichia coli ( n = 6,185; 54.8%), followed by Klebsiella pneumoniae ( n = 1,365; 12.1%) and Pseudomonas aeruginosa ( n = 1,110; 9.8%). Resistance to carbapenems in E. coli was higher in respiratory isolates (imipenem: 5.8%, p = 0.016; meropenem: 5.3%, p < 0.001), with 75.9% producing extended-spectrum ß-lactamases (ESBLs). K. pneumoniae had the highest resistance to ampicillin/sulbactam (52.5%, p = 0.028) and sulfamethoxazole/trimethoprim (62.1%, p = 0.014) in blood isolates, and 63.2% were ESBL-producers ( p = 0.001). In P. aeruginosa , urine isolates showed significantly higher resistance to ceftolozane-tazobactam (24.7%, p = 0.008), ceftazidime-avibactam (36.6%, p < 0.001), and meropenem (34.5%, p = 0.009) compared to other clinical specimens included. For A. baumannii , respiratory isolates had 73.6% resistance to meropenem ( p < 0.001). S. aureus from blood showed 25.7% resistance to oxacillin ( p < 0.004). The most frequent carbapenemase genes were bla OXA−48−like in E. coli (26/56, 46.4%), bla NDM for K. pneumoniae (7/17, 41.2%), bla OXA−24 in A. baumannii (79/108, 73.1%) and bla IMP for P. aeruginosa (18/108, 16.7%).
Conclusion
This surveillance study underscores the elevated levels of antimicrobial resistance, ESBL production, and carbapenemase activity among priority pathogens, including some Enterobacterales , P. aeruginosa , and A. baumannii . These findings emphasize the urgent need to strengthen epidemiologic surveillance programs in Mexican healthcare settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, 66455, Mexico.
- Departamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, 66460, Mexico.
- Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, 14080, Mexico.
- Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Ciudad de México, 14080, Mexico.
- Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Ciudad de México, 14080, Mexico.
- Hospital General y Hospital del niño y la mujer (IMSS Bienestar), Ciudad Obregón, 85000, Sonora, Mexico.
Zitieren
APA
Martínez-Meléndez, A., Garza-González, E., Del Rosario Vázquez-Larios, M., Garibaldi-Rojas, M., Martinez-Guerra, B. A., Mireles-Davalos, C. D., Escalante-Armenta, S. P., Feliciano-Guzmán, J. M., Romero-Romero, D., Del Consuelo Velazquez-Acosta, M., Quintana-Ponce, S., Navarro-Lara, S. A., Aguirre-Torres, J. A., Martínez-Zavaleta, M. G., Castillo-Perez, A. K., Mena-Ramírez, J. P., Choy-Chang, E. V., Avilés-Benítez, L. K., Fong-Camargo, M. G., …, & Franco-Cendejas, R. (2026). The threat of multidrug-resistant microorganisms: active surveillance of key antimicrobial resistant pathogens in 2025 - a report from the INVIFAR network. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-025-05330-2
Vancouver
Martínez-Meléndez A, Garza-González E, Del Rosario Vázquez-Larios M, Garibaldi-Rojas M, Martinez-Guerra BA, Mireles-Davalos CD, et al. The threat of multidrug-resistant microorganisms: active surveillance of key antimicrobial resistant pathogens in 2025 - a report from the INVIFAR network. European Journal of Clinical Microbiology & Infectious Diseases. 2026. doi:10.1007/s10096-025-05330-2
BibTeX
@article{MartnezMelndez2026,
author = {Martínez-Meléndez, Adrián and Garza-González, Elvira and Del Rosario Vázquez-Larios, María and Garibaldi-Rojas, Melissa and Martinez-Guerra, Bernardo Alfonso and Mireles-Davalos, Christian Daniel and Escalante-Armenta, Samuel Pavel and Feliciano-Guzmán, José Manuel and Romero-Romero, Daniel and Del Consuelo Velazquez-Acosta, Maria and Quintana-Ponce, Sandra and Navarro-Lara, Shaúl Ariel and Aguirre-Torres, Jesús Alfonso and Martínez-Zavaleta, María Guadalupe and Castillo-Perez, Ana Karina and Mena-Ramírez, Juan Pablo and Choy-Chang, Elena Victoria and Avilés-Benítez, Laura Karina and Fong-Camargo, María Guadalupe and Couoh-May, Carlos Antonio and López-Gutiérrez, Eduardo and Pérez-Vicelis, Talia and Silva-Gamiño, Aldo Rafael and Rincón-Zuno, Joaquín and Gil-Veloz, Mariana and Zubiate-Tejeda, Héctor Miguel and Ramirez-Alanis, Eloisa and Gutierrez-Brito, Maricruz and Gomez-Espinosa, Josue and García-Romo, Ricardo and Barajas-Magallón, Juan Manuel and Morales-de-la-Peña, Cecilia Teresita and Jacobo-Baca, Guillermo and Ballesteros-Silva, María Bertha and Preciado-Jiménez, Paola Alejandra and Chora-Hernández, Luis David and Márquez-Avalos, Isabel Cristina and Villanueva-Lozano, Hiram and Bolado-Martínez, Enrique and de Dios Castañeda-Duarte, Juan and Padilla-Ibarra, Cecilia and Peralta-Peñuñuri, Victor Hugo and Duarte-Miranda, Lizbeth Soraya and Valenzuela-Oroz, Anabel and Valtierra-Diosdado, Angela Cecilia and González-Melgoza, Paulina Fabiola and Salazar-Mares, Jorge Arturo and Perales-Martínez, Diana Eugenia and Vazquez-Diaz, Marliz Andrea and Huirache-Villalobos, Guadalupe Soledad and Martínez-Lazo, Filiberto Alejandro and Alcaraz-Espejel, Margarita and Vázquez-Olvera, Rodrigo E and Dorado-Del-Rio, Martha and Pérez-Méndez, Iván Ramón and Clemente-Callejas, Zaira Lucero and Cardona-Olguin, Juana Narmy and Sánchez-García, Elisa and Bocanegra-Ibarias, Paola and Franco-Cendejas, Rafael},
title = {The threat of multidrug-resistant microorganisms: active surveillance of key antimicrobial resistant pathogens in 2025 - a report from the INVIFAR network},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2026},
doi = {10.1007/s10096-025-05330-2}
}
EUVIMED